Aurora Cannabis said Wednesday it is acquiring privately-held Reliva in an all stock deal worth $40 million in order to gain entry to the U.S. cannabinoid markets. Canadian-based Aurora said the deal should be "immediately accretive to Aurora on an adjusted EBITDA basis." The move comes just days after Aurora completed a 1-for-12 reverse stock split to avoid being delisted on the New York Stock Exchange. Read More...
Aurora Cannabis said Wednesday it is acquiring privately-held Reliva in an all stock deal worth $40 million in order to gain entry to the U.S. cannabinoid markets. Canadian-based Aurora said the deal should be “immediately accretive to Aurora on an adjusted EBITDA basis.” The move comes just days after Aurora completed a 1-for-12 reverse stock split to avoid being delisted on the New York Stock Exchange.
Add Comment